Outcomes of nonagenarians after transcatheter aortic valve implantation

ABSTRACT Introduction and objectives: Nonagenarians are a fast-growing age group among cardiovascular patients, especially with aortic stenosis, but data about their prognosis after transcatheter aortic valve implantation (TAVI) is scarce. The objective of our study is to analyze the baseline charac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pedro L. Cepas-Guillén, Ander Regueiro, Darío Sanmiguel Cervera, Roberto Blanco Mata, Juan Francisco Oteo, Ignacio Amat-Santos, Francisco Ten, Juan Manuel Nogales, Eduard Fernández-Nofrerías, Vicente Mainar, Garikoit Lasa-Larraya, Leire Andraka, José Antonio Baz-Alonso, María Cruz Ferrer, Eduardo Pinar, Rafael Romaguera, Carlos Cuellas Ramón, Fernando Alfonso, Cristóbal A. Urbano-Carrillo, Sergio García-Blas, Antonio Piñero, Agustín Albarrán, Rafael Ruiz-Salmerón, José Moreu, Óscar Gil Albarova, José M. Melero, Tomás Heredia Cambra, Xavier Freixa, Manel Sabaté
Formato: article
Lenguaje:EN
ES
Publicado: Permanyer 2021
Materias:
R
Acceso en línea:https://doaj.org/article/cf7b9677b3cc4a5a88af25dc1558bb20
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cf7b9677b3cc4a5a88af25dc1558bb20
record_format dspace
spelling oai:doaj.org-article:cf7b9677b3cc4a5a88af25dc1558bb202021-11-16T10:23:11ZOutcomes of nonagenarians after transcatheter aortic valve implantation10.24875/RECICE.M210002202604-7322https://doaj.org/article/cf7b9677b3cc4a5a88af25dc1558bb202021-11-01T00:00:00Zhttps://recintervcardiol.org/en/index.php?option=com_content&view=article&id=681https://doaj.org/toc/2604-7322ABSTRACT Introduction and objectives: Nonagenarians are a fast-growing age group among cardiovascular patients, especially with aortic stenosis, but data about their prognosis after transcatheter aortic valve implantation (TAVI) is scarce. The objective of our study is to analyze the baseline characteristics of nonagenarians treated with TAVI and determine whether age ≥ 90 years is associated with a worse prognosis compared to non-nonagenarian patients. Methods: We included all patients ≥75 years enrolled in the multicenter prospective Spanish TAVI registry between 2009 and 2018. Patients < 75 years were excluded. Results: A total of 8073 elderly patients (≥ 75 years) from 46 Spanish centers were enrolled in the Spanish TAVI registry; 7686 were between ≥ 75 and < 90 years old (95.2%), and 387 were nonagenarian patients (4.79%). A gradual increase of nonagenarians was observed. The transfemoral access was used in 91.6% of the cases, predominantly among the nonagenarian patients (91.4% vs 95.1%, P = .01). Nonagenarians were more likely to die during their hospital stay (4.3% vs 7.0% among nonagenarians, P = .01). However, no difference was seen in the all-cause mortality rates reported at the 1-year follow-up (8.8% vs 11.3%, P =.07). In the multivariate analysis, age ≥ 90 years was not independently associated with a higher adjusted all-cause mortality rate (HR, 1.37, 95%CI, 0.91–1.97, P = .14). The baseline creatinine levels, and the in-hospital bleeding complications were all associated with a worse long-term prognosis in nonagenarians treated with TAVI. Conclusions: Nonagenarians are a very high-risk and growing population with severe AS in whom TAVI may be a safe and effective strategy. Careful patient selection by the TAVI heart team is mandatory to achieve maximum efficiency in this population where the baseline kidney function and bleeding complications may determine the long-term prognosis after TAVI.Pedro L. Cepas-GuillénAnder RegueiroDarío Sanmiguel CerveraRoberto Blanco MataJuan Francisco OteoIgnacio Amat-SantosFrancisco TenJuan Manuel NogalesEduard Fernández-NofreríasVicente MainarGarikoit Lasa-LarrayaLeire AndrakaJosé Antonio Baz-AlonsoMaría Cruz FerrerEduardo PinarRafael RomagueraCarlos Cuellas RamónFernando AlfonsoCristóbal A. Urbano-CarrilloSergio García-BlasAntonio PiñeroAgustín AlbarránRafael Ruiz-SalmerónJosé MoreuÓscar Gil AlbarovaJosé M. MeleroTomás Heredia CambraXavier FreixaManel SabatéPermanyerarticleTAVI Aortic stenosis Nonagenarians ElderlyMedicineRENESREC: Interventional Cardiology (English Ed.), Vol 3, Iss 4, Pp 250-257 (2021)
institution DOAJ
collection DOAJ
language EN
ES
topic TAVI
Aortic stenosis
Nonagenarians
Elderly
Medicine
R
spellingShingle TAVI
Aortic stenosis
Nonagenarians
Elderly
Medicine
R
Pedro L. Cepas-Guillén
Ander Regueiro
Darío Sanmiguel Cervera
Roberto Blanco Mata
Juan Francisco Oteo
Ignacio Amat-Santos
Francisco Ten
Juan Manuel Nogales
Eduard Fernández-Nofrerías
Vicente Mainar
Garikoit Lasa-Larraya
Leire Andraka
José Antonio Baz-Alonso
María Cruz Ferrer
Eduardo Pinar
Rafael Romaguera
Carlos Cuellas Ramón
Fernando Alfonso
Cristóbal A. Urbano-Carrillo
Sergio García-Blas
Antonio Piñero
Agustín Albarrán
Rafael Ruiz-Salmerón
José Moreu
Óscar Gil Albarova
José M. Melero
Tomás Heredia Cambra
Xavier Freixa
Manel Sabaté
Outcomes of nonagenarians after transcatheter aortic valve implantation
description ABSTRACT Introduction and objectives: Nonagenarians are a fast-growing age group among cardiovascular patients, especially with aortic stenosis, but data about their prognosis after transcatheter aortic valve implantation (TAVI) is scarce. The objective of our study is to analyze the baseline characteristics of nonagenarians treated with TAVI and determine whether age ≥ 90 years is associated with a worse prognosis compared to non-nonagenarian patients. Methods: We included all patients ≥75 years enrolled in the multicenter prospective Spanish TAVI registry between 2009 and 2018. Patients < 75 years were excluded. Results: A total of 8073 elderly patients (≥ 75 years) from 46 Spanish centers were enrolled in the Spanish TAVI registry; 7686 were between ≥ 75 and < 90 years old (95.2%), and 387 were nonagenarian patients (4.79%). A gradual increase of nonagenarians was observed. The transfemoral access was used in 91.6% of the cases, predominantly among the nonagenarian patients (91.4% vs 95.1%, P = .01). Nonagenarians were more likely to die during their hospital stay (4.3% vs 7.0% among nonagenarians, P = .01). However, no difference was seen in the all-cause mortality rates reported at the 1-year follow-up (8.8% vs 11.3%, P =.07). In the multivariate analysis, age ≥ 90 years was not independently associated with a higher adjusted all-cause mortality rate (HR, 1.37, 95%CI, 0.91–1.97, P = .14). The baseline creatinine levels, and the in-hospital bleeding complications were all associated with a worse long-term prognosis in nonagenarians treated with TAVI. Conclusions: Nonagenarians are a very high-risk and growing population with severe AS in whom TAVI may be a safe and effective strategy. Careful patient selection by the TAVI heart team is mandatory to achieve maximum efficiency in this population where the baseline kidney function and bleeding complications may determine the long-term prognosis after TAVI.
format article
author Pedro L. Cepas-Guillén
Ander Regueiro
Darío Sanmiguel Cervera
Roberto Blanco Mata
Juan Francisco Oteo
Ignacio Amat-Santos
Francisco Ten
Juan Manuel Nogales
Eduard Fernández-Nofrerías
Vicente Mainar
Garikoit Lasa-Larraya
Leire Andraka
José Antonio Baz-Alonso
María Cruz Ferrer
Eduardo Pinar
Rafael Romaguera
Carlos Cuellas Ramón
Fernando Alfonso
Cristóbal A. Urbano-Carrillo
Sergio García-Blas
Antonio Piñero
Agustín Albarrán
Rafael Ruiz-Salmerón
José Moreu
Óscar Gil Albarova
José M. Melero
Tomás Heredia Cambra
Xavier Freixa
Manel Sabaté
author_facet Pedro L. Cepas-Guillén
Ander Regueiro
Darío Sanmiguel Cervera
Roberto Blanco Mata
Juan Francisco Oteo
Ignacio Amat-Santos
Francisco Ten
Juan Manuel Nogales
Eduard Fernández-Nofrerías
Vicente Mainar
Garikoit Lasa-Larraya
Leire Andraka
José Antonio Baz-Alonso
María Cruz Ferrer
Eduardo Pinar
Rafael Romaguera
Carlos Cuellas Ramón
Fernando Alfonso
Cristóbal A. Urbano-Carrillo
Sergio García-Blas
Antonio Piñero
Agustín Albarrán
Rafael Ruiz-Salmerón
José Moreu
Óscar Gil Albarova
José M. Melero
Tomás Heredia Cambra
Xavier Freixa
Manel Sabaté
author_sort Pedro L. Cepas-Guillén
title Outcomes of nonagenarians after transcatheter aortic valve implantation
title_short Outcomes of nonagenarians after transcatheter aortic valve implantation
title_full Outcomes of nonagenarians after transcatheter aortic valve implantation
title_fullStr Outcomes of nonagenarians after transcatheter aortic valve implantation
title_full_unstemmed Outcomes of nonagenarians after transcatheter aortic valve implantation
title_sort outcomes of nonagenarians after transcatheter aortic valve implantation
publisher Permanyer
publishDate 2021
url https://doaj.org/article/cf7b9677b3cc4a5a88af25dc1558bb20
work_keys_str_mv AT pedrolcepasguillen outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT anderregueiro outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT dariosanmiguelcervera outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT robertoblancomata outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT juanfranciscooteo outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT ignacioamatsantos outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT franciscoten outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT juanmanuelnogales outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT eduardfernandeznofrerias outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT vicentemainar outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT garikoitlasalarraya outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT leireandraka outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT joseantoniobazalonso outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT mariacruzferrer outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT eduardopinar outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT rafaelromaguera outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT carloscuellasramon outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT fernandoalfonso outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT cristobalaurbanocarrillo outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT sergiogarciablas outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT antoniopinero outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT agustinalbarran outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT rafaelruizsalmeron outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT josemoreu outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT oscargilalbarova outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT josemmelero outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT tomasherediacambra outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT xavierfreixa outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
AT manelsabate outcomesofnonagenariansaftertranscatheteraorticvalveimplantation
_version_ 1718426575422095360